Researchers from the Cyprus Institute of Neurology and Genetics and collaborators report the development of a gene silencing therapy for Charcot-Marie-Tooth type 1A.

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...

In the coming weeks, Quantum Biopharma will seek FDA permission for a clinical trial testing Lucid-MS, its therapy to slow myelin loss in MS.

Strategic Partnership with Global Clinical Research Organization (CRO) Signifies Advancement in Clinical Development of Lucid ...

Detailed price information for Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM-CN) from The Globe and Mail including charting and trades.

An invisible but often debilitating exhaustion, fatigue in CIDP can affect the body and mind, which not only leaves you physically tired but can also make you feel less alert, awake, and motivated.

Introduction: White matter hyperintensities of aging (leukoaraiosis), frequently seen on MRI, have an etiology that remains obscure. The underlying neuropathology of these lesions includes prominent ...

A preclinical study by biomedical scientists at the University of California, Riverside, has shown why some people with multiple sclerosis, or MS, also suffer from seizures — a debilitating ...

RIVERSIDE, Calif. -- A preclinical study by biomedical scientists at the University of California, Riverside, has shown why some people with multiple sclerosis, or MS, also suffer from seizures — a ...

Iron dysregulation contributes to MS progression through oxidative stress, ferroptosis, and immune activation, affecting neuronal and immune cell function. Both iron overload and deficiency exacerbate ...